Pathogenesis and promising non-invasive markers for preeclampsia.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3784103)

Published in Obstet Gynecol Sci on January 09, 2013

Authors

Young Ju Kim1

Author Affiliations

1: Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, Seoul, Korea.

Articles cited by this

The L-arginine-nitric oxide pathway. N Engl J Med (1993) 14.38

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06

Implantation and the placenta: key pieces of the development puzzle. Science (1994) 4.75

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest (1997) 3.76

Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int (2007) 2.87

Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol (2007) 2.78

Pathogenesis of preeclampsia. Annu Rev Pathol (2010) 2.66

A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol (1994) 2.56

Epigenetics and microRNAs. Pediatr Res (2007) 2.52

Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension (2008) 2.42

Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol (2007) 2.40

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension (2005) 2.22

Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev (2009) 2.17

Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol (2000) 1.99

NO and angiogenesis. Atheroscler Suppl (2003) 1.64

Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem (2002) 1.51

Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol (2010) 1.17

Preeclampsia and the systemic inflammatory response. Semin Nephrol (2004) 1.13

Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol (2005) 1.13

Genetic and epigenetic factors contribute to the onset of preeclampsia. Mol Cell Endocrinol (2007) 1.09

Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide. J Physiol (2005) 1.04

Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension (2006) 1.02

Angiotensin II levels in hypertensive and normotensive pregnancies. Br J Obstet Gynaecol (1991) 1.01

Expression profile of trophoblast invasion-associated genes in the pre-eclamptic placenta. Br J Biomed Sci (2003) 0.99

Marinobufagenin impairs first trimester cytotrophoblast differentiation. Placenta (2006) 0.92

Molecular mechanisms of preeclampsia. J Pregnancy (2012) 0.90

A proinflammatory cytokine response is present in the fetal placental vasculature in placental insufficiency. Am J Obstet Gynecol (2003) 0.89

Epigenetics and microRNAs in preeclampsia. Clin Exp Hypertens (2012) 0.88

Marinobufagenin is an upstream modulator of Gadd45a stress signaling in preeclampsia. Biochim Biophys Acta (2010) 0.85

Effects of an endogenous ouabainlike compound on heart and aorta. Hypertension (1991) 0.84

Epigenetics in women's health care. Mt Sinai J Med (2010) 0.84

Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome. Transl Res (2012) 0.84

Resibufogenin administration prevents oxidative stress in a rat model of human preeclampsia. Hypertens Pregnancy (2010) 0.80